| Organism name | Rosa canina |
|---|---|
| Genus | Rosa |
| Family | Rosaceae |
| Kingdom | Plantae |
| Linked NCBI taxonomy name | Rosa canina |
|---|---|
| Linked NCBI taxonomy ID | 74635 |
| Linked level | species |
| Family in NCBI taxonomy | Rosaceae |
|---|---|
| ID | 3745 |
| Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
|---|---|
| ID | 33090 |
| Plant class | rosids |
|---|---|
| ID | 71275 |
| Species | Activity |
|---|---|
| Rosa canina L. | Analgesic |
| Rosa canina L. | Antidiarrheic |
| Rosa canina L. | Antioxidant |
| Rosa canina L. | Antiradicular |
| Rosa canina L. | Antiseptic |
| Rosa canina L. | Antispasmodic |
| Rosa canina L. | Astringent |
| Rosa canina L. | Demulcent |
| Rosa canina L. | Diuretic |
| Rosa canina L. | Hypoglycemic |
| Rosa canina L. | Laxative |
| Rosa canina L. | Lipoxygenase Inhibitor |
| Rosa canina L. | Nervine |
| Rosa canina L. | Vermifuge |
| KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
|---|---|---|---|---|---|---|---|---|
|
C00000911
|
Lycopene
/ all-trans-Lycopene |
CHEMBL501174
CHEMBL1984187 |
C015329
|
6 / 13 / 13 | 84 / 13 | No. 97 | No. 59 |
|
|
C00003785
|
Rubixanthin
|
No. 131 | No. 59 |
|
||||
|
C00002668
|
Protocatechuic acid
/ 3,4-Dihydroxybenzoic acid |
CHEMBL37537
|
C009091
|
33 / 19 / 19 | 2 / 0 | No. 817 | No. 81 |
|
|
C00002682
|
Vanillic acid
/ 3-Methoxy-4-hydroxybenzoic acid |
CHEMBL120568
|
D014641
|
5 / 3 / 3 | 5 / 0 | No. 1073 |
|
| accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|
| O75496 | Geminin | Unclassified protein | C00000911 C00002668 | 0 / 0 |
| Q9UNA4 | DNA polymerase iota | Enzyme | C00002668 C00002682 | 0 / 0 |
| P03372 | Estrogen receptor | NR3A1 | C00002668 C00002682 | 1 / 1 |
| P15121 | Aldose reductase | Enzyme | C00002668 C00002682 | 0 / 0 |
| P07711 | Cathepsin L1 | C1A | C00002668 | 0 / 0 |
| P22894 | Neutrophil collagenase | M10A | C00002668 | 0 / 0 |
| P14780 | Matrix metalloproteinase-9 | M10A | C00002668 | 2 / 2 |
| P02545 | Prelamin-A/C | Unclassified protein | C00000911 | 11 / 10 |
| P00918 | Carbonic anhydrase 2 | Lyase | C00002668 | 1 / 2 |
| P02768 | Serum albumin | Secreted protein | C00002668 | 0 / 0 |
| Q9GZT9 | Egl nine homolog 1 | Enzyme | C00002668 | 1 / 1 |
| P11473 | Vitamin D3 receptor | NR1I1 | C00000911 | 2 / 3 |
| P23280 | Carbonic anhydrase 6 | Lyase | C00002668 | 0 / 0 |
| Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00002668 | 0 / 0 |
| P16581 | E-selectin | Adhesion | C00002668 | 0 / 0 |
| O43570 | Carbonic anhydrase 12 | Lyase | C00002668 | 1 / 2 |
| P42858 | Huntingtin | Unclassified protein | C00002682 | 1 / 1 |
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002668 | 0 / 0 |
| P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00002668 | 1 / 1 |
| P00915 | Carbonic anhydrase 1 | Lyase | C00002668 | 0 / 0 |
| P43166 | Carbonic anhydrase 7 | Lyase | C00002668 | 0 / 0 |
| P03956 | Interstitial collagenase | M10A | C00002668 | 0 / 1 |
| Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002668 | 0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000911 | 0 / 0 |
| Q16790 | Carbonic anhydrase 9 | Lyase | C00002668 | 0 / 1 |
| P08253 | 72 kDa type IV collagenase | M10A | C00002668 | 1 / 3 |
| P06746 | DNA polymerase beta | Enzyme | C00002668 | 0 / 0 |
| P51580 | Thiopurine S-methyltransferase | Enzyme | C00002682 | 1 / 1 |
| P14151 | L-selectin | Adhesion | C00002668 | 0 / 0 |
| P16109 | P-selectin | Adhesion | C00002668 | 1 / 0 |
| Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002668 | 3 / 0 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | C00002668 | 4 / 3 |
| P08254 | Stromelysin-1 | M10A | C00002668 | 1 / 0 |
| P22748 | Carbonic anhydrase 4 | Lyase | C00002668 | 1 / 1 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | C00000911 | 0 / 0 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00002668 | 0 / 0 |
| Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000911 | 0 / 0 |
| Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002668 | 0 / 1 |
| Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002668 | 1 / 4 |
| O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002668 | 0 / 0 |
| gene | gene name | gene description | KNApSAcK metabolite in interactions |
|---|---|---|---|
| 1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002668
|
| 2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00002668
|
| 118 | ADD1, ADDA | adducin 1 (alpha) |
C00000911
|
| 177 | AGER, RAGE | advanced glycosylation end product-specific receptor |
C00000911
|
| 196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000911
|
| 207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000911
|
| 367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000911
|
| 571 | BACH1, BACH-1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
C00000911
|
| 8314 | BAP1, HUCEP-13, UCHL2 | BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) (EC:3.4.19.12) |
C00000911
|
| 673 | BRAF, B-RAF1, BRAF1, NS7, RAFB1 | v-raf murine sarcoma viral oncogene homolog B (EC:2.7.11.1) |
C00000911
|
| 841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000911
|
| 847 | CAT | catalase (EC:1.11.1.6) |
C00000911
|
| 595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000911
|
| 898 | CCNE1, CCNE | cyclin E1 |
C00000911
|
| 983 | CDK1, CDC2, CDC28A, P34CDC2 | cyclin-dependent kinase 1 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
| 1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00000911
|
| 1020 | CDK5, PSSALRE | cyclin-dependent kinase 5 (EC:2.7.11.22) |
C00000911
|
| 1022 | CDK7, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15 | cyclin-dependent kinase 7 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
| 1025 | CDK9, C-2k, CDC2L4, CTK1, PITALRE, TAK | cyclin-dependent kinase 9 (EC:2.7.11.23 2.7.11.22) |
C00000911
|
| 1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000911
|
| 1113 | CHGA, CGA | chromogranin A (parathyroid secretory protein 1) |
C00000911
|
| 1114 | CHGB, SCG1 | chromogranin B (secretogranin 1) |
C00000911
|
| 23418 | CRB1, LCA8, RP12 | crumbs homolog 1 (Drosophila) |
C00000911
|
| 1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000911
|
| 1643 | DDB2, DDBB, UV-DDB2 | damage-specific DNA binding protein 2, 48kDa |
C00000911
|
| 1981 | EIF4G1, EIF-4G1, EIF4F, EIF4G, EIF4GI, P220, PARK18 | eukaryotic translation initiation factor 4 gamma, 1 |
C00000911
|
| 2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000911
|
| 2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000911
|
| 2176 | FANCC, FA3, FAC, FACC | Fanconi anemia, complementation group C |
C00000911
|
| 2188 | FANCF, FAF | Fanconi anemia, complementation group F |
C00000911
|
| 356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000911
|
| 2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00000911
|
| 2701 | GJA4, CX37 | gap junction protein, alpha 4, 37kDa |
C00000911
|
| 2702 | GJA5, ATFB11, CX40 | gap junction protein, alpha 5, 40kDa |
C00000911
|
| 2879 | GPX4, GPx-4, GSHPx-4, MCSP, PHGPx, snGPx, snPHGPx | glutathione peroxidase 4 (EC:1.11.1.12) |
C00000911
|
| 3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00000911
|
| 3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000911
|
| 3479 | IGF1, IGF-I, IGF1A, IGFI | insulin-like growth factor 1 (somatomedin C) |
C00000911
|
| 3480 | IGF1R, CD221, IGFIR, IGFR, JTK13 | insulin-like growth factor 1 receptor (EC:2.7.10.1) |
C00000911
|
| 3485 | IGFBP2, IBP2, IGF-BP53 | insulin-like growth factor binding protein 2, 36kDa |
C00000911
|
| 3713 | IVL | involucrin |
C00000911
|
| 3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00000911
|
| 3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00000911
|
| 3796 | KIF2A, CDCBM3, HK2, KIF2 | kinesin heavy chain member 2A |
C00000911
|
| 3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00000911
|
| 3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000911
|
| 3988 | LIPA, CESD, LAL | lipase A, lysosomal acid, cholesterol esterase (EC:3.1.1.13) |
C00000911
|
| 5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000911
|
| 5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000911
|
| 6416 | MAP2K4, JNKK, JNKK1, MAPKK4, MEK4, MKK4, PRKMK4, SAPKK-1, SAPKK1, SEK1, SERK1, SKK1 | mitogen-activated protein kinase kinase 4 (EC:2.7.12.2) |
C00000911
|
| 5608 | MAP2K6, MAPKK6, MEK6, MKK6, PRKMK6, SAPKK-3, SAPKK3 | mitogen-activated protein kinase kinase 6 (EC:2.7.12.2) |
C00000911
|
| 1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00000911
|
| 5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000911
|
| 5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00000911
|
| 4247 | MGAT2, CDG2A, CDGS2, GLCNACTII, GNT-II, GNT2 | mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (EC:2.4.1.143) |
C00000911
|
| 100507436 | MICA, MIC-A, PERB11.1 | MHC class I polypeptide-related sequence A |
C00000911
|
| 4292 | MLH1, COCA2, FCC2, HNPCC, HNPCC2, hMLH1 | mutL homolog 1 |
C00000911
|
| 4436 | MSH2, COCA1, FCC1, HNPCC, HNPCC1, LCFS2 | mutS homolog 2 |
C00000911
|
| 2956 | MSH6, GTBP, GTMBP, HNPCC5, HSAP, p160 | mutS homolog 6 |
C00000911
|
| 4842 | NOS1, IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS | nitric oxide synthase 1 (neuronal) (EC:1.14.13.39) |
C00000911
|
| 8021 | NUP214, CAIN, CAN, D9S46E, N214, p250 | nucleoporin 214kDa |
C00000911
|
| 5320 | PLA2G2A, MOM1, PLA2, PLA2B, PLA2L, PLA2S, PLAS1, sPLA2 | phospholipase A2, group IIA (platelets, synovial fluid) (EC:3.1.1.4) |
C00000911
|
| 5591 | PRKDC, DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, XRCC7, p350 | protein kinase, DNA-activated, catalytic polypeptide (EC:2.7.11.1) |
C00000911
|
| 10111 | RAD50, NBSLD, RAD502, hRad50 | RAD50 homolog (S. cerevisiae) |
C00000911
|
| 8045 | RASSF7, C11orf13, HRAS1, HRC1 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 7 |
C00000911
|
| 5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000911
|
| 5962 | RDX, DFNB24 | radixin |
C00000911
|
| 6195 | RPS6KA1, HU-1, MAPKAPK1A, RSK, RSK1 | ribosomal protein S6 kinase, 90kDa, polypeptide 1 (EC:2.7.11.1) |
C00000911
|
| 6197 | RPS6KA3, CLS, HU-3, ISPK-1, MAPKAPK1B, MRX19, RSK, RSK2, S6K-alpha3, p90-RSK2, pp90RSK2 | ribosomal protein S6 kinase, 90kDa, polypeptide 3 (EC:2.7.11.1) |
C00000911
|
| 6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00000911
|
| 6401 | SELE, CD62E, ELAM, ELAM1, ESEL, LECAM2 | selectin E |
C00000911
|
| 6414 | SEPP1, SELP, SeP | selenoprotein P, plasma, 1 |
C00000911
|
| 4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00000911
|
| 8243 | SMC1A, CDLS2, DXS423E, SB1.8, SMC1, SMC1L1, SMC1alpha, SMCB | structural maintenance of chromosomes 1A |
C00000911
|
| 6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00000911
|
| 7031 | TFF1, BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2 | trefoil factor 1 |
C00000911
|
| 7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00000911
|
| 7039 | TGFA, TFGA | transforming growth factor, alpha |
C00000911
|
| 7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00000911
|
| 7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000911
|
| 7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000911
|
| 7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000911
|
| 7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00000911
|
| 7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00000911
|
| 7485 | WRB, CHD5 | tryptophan rich basic protein |
C00000911
|
| 7697 | ZNF138, pHZ-32 | zinc finger protein 138 |
C00000911
|
| 4846 | NOS3, ECNOS, eNOS | nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) |
C00002682
|
| 54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00002682
|
| 54659 | UGT1A3, UDPGT, UDPGT_1-3, UGT-1C, UGT1-03, UGT1.3, UGT1C | UDP glucuronosyltransferase 1 family, polypeptide A3 (EC:2.4.1.17) |
C00002682
|
| 54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00002682
|
| 54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00002682
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #600807 | Asthma, susceptibility to |
Q13093
|
| #115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
| #212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
| #605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
| #614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
| #181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
| #609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
| #615363 | Estrogen resistance; estrr |
P03372
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #232300 | Glycogen storage disease ii |
P10253
|
| #610140 | Heart-hand syndrome, slovenian type |
P02545
|
| #143100 | Huntington disease; hd |
P42858
|
| #176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
| #143860 | Hyperchlorhidrosis, isolated |
O43570
|
| #147050 | Ige responsiveness, atopic; iger |
Q13093
|
| #603932 | Intervertebral disc disease; idd |
P14780
|
| #151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
| #248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
| #613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
| #259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
| #613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
| #159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
| #614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
| #275210 | Restrictive dermopathy, lethal |
P02545
|
| #600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
| #601367 | Stroke, ischemic |
P16109
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #610460 | Thiopurine s-methyltransferase deficiency |
P51580
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
| KEGG | name | UniProt |
|---|---|---|
| H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
| H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
| H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
| H00436 | Osteopetrosis |
P00918
(related)
|
| H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
| H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
| H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
| H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
| H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
| H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
| H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
| H00663 | Restrictive dermopathy |
P02545
(related)
|
| H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
| H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
| H00026 | Endometrial Cancer |
P03372
(marker)
|
| H00028 | Choriocarcinoma |
P03956
(related)
P08253 (related) |
| H00025 | Penile cancer |
P08253
(related)
P14780 (related) |
| H00472 | Torg-Winchester syndrome |
P08253
(related)
|
| H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H00479 | Metaphyseal dysplasias |
P14780
(related)
|
| H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
| H00059 | Huntington's disease (HD) |
P42858
(related)
|
| H00964 | Thiopurine S-methyltransferase deficiency (TPMT deficiency) |
P51580
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) |
| H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
| H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
| H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
| H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
| MESH or OMIM | name |
KNApSAcK
metabolite |
|---|---|---|
| D056486 | Drug-Induced Liver Injury |
C00000911
|
| D006943 | Hyperglycemia |
C00000911
|
| D006965 | Hyperplasia |
C00000911
|
| D007248 | Infertility, Male |
C00000911
|
| D007249 | Inflammation |
C00000911
|
| D007674 | Kidney Diseases |
C00000911
|
| D009369 | Neoplasms |
C00000911
|
| D020258 | Neurotoxicity Syndromes |
C00000911
|
| D011471 | Prostatic Neoplasms |
C00000911
|
| D012878 | Skin Neoplasms |
C00000911
|
| D013733 | Testicular Diseases |
C00000911
|
| D014178 | Translocation, Genetic |
C00000911
|
| D015431 | Weight Loss |
C00000911
|